{
  "report_rows": [
    {
      "kpi": "Net Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3,970M vs. cons $3,920M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EBITDA (Q2 2026)",
      "prediction": "MISS",
      "answer": "pred ~$322M vs. cons $331.6M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Gross Margin % (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~28.1% vs. cons ~28.3%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Adj. EBITDA (FY 2026)",
      "prediction": "LOWER",
      "answer": "guide mid ~$1,225M vs. cons $1,202M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Revenue (FY 2026)",
      "prediction": "LOWER",
      "answer": "guide mid ~$15.0B vs. cons $14,768M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 Revenue/EBITDA (Q3 2026)",
      "prediction": "LOWER",
      "answer": "guide below current Q3 consensus",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 initial relief on revenue beat, then sell-side cuts Q3/FY estimates on guide narrowed lower; archetype D 5-day pattern",
  "day5_confidence": "MEDIUM"
}